Novartis Crosses Below Key Moving Average Level

Share to Facebook Share to Twitter Share to Linkedin In trading on Tuesday, shares of Novartis crossed below their 200 day moving average of $85.10, changing hands as low as $84.78 per share. Novartis...

The 12 Best Income Investments for 2023, According to Barron’s

While it might not be a feast now for income-oriented investors, it’s a lot better than the famine that prevailed for much of the past decade. Yields on a range of bond and bond-related investments ro...

The Best Income Investing Ideas for 2023

While it might not be a feast now for income-oriented investors, it’s a lot better than the famine that prevailed for much of the past decade. Yields on a range of bond and bond-related investments ro...

Novartis Looks Appealing, Based on Drug Pipeline and Planned Spinoff

Text size These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the vi...

Novartis Will Cut 8,000 Jobs Under CEO’s Shake-Up Plan

Text size Vasant Narasimhan, CEO of Novartis. ERIC PIERMONT/AFP/Getty Images Pharmaceutical giant Novartis said Tuesday it will lay off more than 7% of its workforce, just a few months after CEO Vas N...

Opinion: AT&T and 4 more unloved dividend stocks to buy in a ‘risk-off’ era

With stocks off to one of their worst starts to the year since the 2008-2009 financial crisis, it’s no longer crazy to talk about a sustained period of market volatility or a prolonged “risk off” envi...